Home › Funds › Citigroup Inc › TERN

Citigroup Inc position in TERN

TERNS PHARMACEUTICALS INC

Latest position (Q1 2026)51.55K sh
Reported value held$2.72M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 1.59K $17.00K New
Q4 2021 4.29K $30.00K Add
Q1 2022 1.07K $3.00K Reduce
Q2 2022 519 $1.00K Reduce
Q3 2022 701 $4.00K Add
Q4 2022 46.05K $468.77K Add
Q1 2023 45.39K $537.45K Reduce
Q2 2023 14.51K $126.95K Reduce
Q3 2023 837 $4.21K Reduce
Q4 2023 7.09K $46.04K Add
Q1 2024 157.56K $1.03M Add
Q2 2024 361.08K $2.46M Add
Q3 2024 49.66K $414.12K Reduce
Q4 2024 59.18K $327.86K Add
Q1 2025 54.18K $149.54K Reduce
Q2 2025 38.27K $142.76K Reduce
Q3 2025 12.61K $94.72K Reduce
Q4 2025 69.47K $2.81M Add
Q1 2026 51.55K $2.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding TERN

All TERN fund holders →